BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Xencor Announces Change to Ultomiris® Royalty Revenue Forecast

  March 5, 2026

   · 

  4 min read
• Press Releases

  PepGen Announces Regulatory Updates on FREEDOM2

  March 5, 2026

   · 

  6 min read
• Press Releases

  Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - March 4, 2026

  March 5, 2026

   · 

  1 min read
• Press Releases

  Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

  March 5, 2026

   · 

  1 min read
• Press Releases

  Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update

  March 5, 2026

   · 

  3 min read
• Press Releases

  Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference

  March 5, 2026

   · 

  4 min read
• Press Releases

  Medline Inc. announces pricing of secondary offering of class A common stock

  March 5, 2026

   · 

  5 min read
• Press Releases

  Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency

  March 5, 2026

   · 

  19 min read
• Press Releases

  Cadonilimab Achieves 100% 24-Month OS in Complete Responders in R/M Cervical Cancer Based on Long-Term Phase II Results

  March 5, 2026

   · 

  6 min read
• Press Releases

  BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call

  March 5, 2026

   · 

  3 min read